TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XELLERA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

XELLERA

ST13

US500000088977261

Class

9, 10, 40, 42, 44

Filing

88977261

Registration

6211226

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

12/02/2025

Classification

Registered

Trademark type

Combined

Nice classes

9, 10, 40, 42, 44

Filing date

05/27/2019

Registration date

12/01/2020

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/01/2020

Last transaction

12/02/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

5

Owner type

99

Owner location

HUNG HOM, KLN, HK

Examiner

KAPLAN,VALERIE ELIZABETH

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized design of the letter "X" and the stylized wording "ellera".

Holders and representatives

Holders

XELLERA THERAPEUTICS LIMITED

Representatives

Kevin O'Keefe

Technical classification

Nice Classes

Class 9Class 10Class 40Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Bioreactor for cell culturing; Bioreactors for laboratory use; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Computer-controlled electronic apparatus for electrophysiological measurement and testing of cells

Class 10

Apparatus for the regeneration of stem cells for medical purposes; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical diagnostic apparatus for testing blood antigens and antibodies

Class 40

Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; Contract manufacturing in the field of biotechnology; Cryogenic preservation; Cryopreservation of human tissue; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Manufacture of pharmaceuticals to order and/or specification of others; Manufacturing services for others in the field of stem cells; Providing technical information in the field of pharmaceutical manufacturing

Class 42

Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug discovery services; Industrial research in the field of regenerative and reparative therapies; Medical laboratory services; Medical research; Pharmaceutical drug development services; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of vaccines and medicines; Scientific research; Scientific research and development; Scientific research in the field of gene therapy; Stem cell research services; Technology research in the field of regenerative and reparative therapies

Class 44

Blood bank services; Health care services, namely, regenerative and reparative therapies; Human tissue bank services; Medical care; Medical services; Medical services in the field of regenerative and reparative therapies; Medical testing for diagnostic or treatment purposes in the field of regenerative and reparative therapies; Organ and tissue bank services; Stem cell therapy services

Publications

History of USPTO decisions and trademark events.

34 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/01/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/08/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/08/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/08/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

12/01/2020

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

10/29/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

10/08/2020

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

10/08/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/07/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/12/2020

PUBO

PUBLISHED FOR OPPOSITION

05/12/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/22/2020

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

04/09/2020

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

04/03/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/26/2020

DPCC

DIVISIONAL PROCESSING COMPLETE

03/26/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/24/2020

ALIE

ASSIGNED TO LIE

02/27/2020

DRRR

DIVISIONAL REQUEST RECEIVED

02/21/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/21/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/21/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/21/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/21/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/21/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/21/2020

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

02/21/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/31/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/31/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/21/2019

GNRT

NON-FINAL ACTION E-MAILED

08/21/2019

CNRT

NON-FINAL ACTION WRITTEN

08/21/2019

DOCK

ASSIGNED TO EXAMINER

08/15/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/11/2019

NWAP

NEW APPLICATION ENTERED

05/30/2019

Continuous trademark protection

Get notified about every new filing that threatens XELLERA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.